{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Fang L"],"funding":["Natural Science Foundation of Chongqing China"],"pagination":["366"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11468476"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["24(1)"],"pubmed_abstract":["<h4>Objective</h4>Given the lack of global consensus on anesthesia selection for peritoneal dialysis catheter (PDC) placement via open surgery, this study investigates the safety and efficacy of combining local infiltration anesthesia (LIA) with monitored anesthesia care (MAC) in patients with end-stage renal disease (ESRD).<h4>Methods</h4>This retrospective analysis of ESRD patients who underwent open surgical placement of PDC in the Department of Nephrology, the First Affiliated Hospital of the Army Medical University from 1 August 2020 to 31 May 2022. Patients were categorized into two groups based on anesthesia method: LIA group and LIA + MA group. MA was defined as preoperative sedation (0.2-0.7 µg/kg/h) with dexmedetomidine injection (Huidrican trade name, DEX), and intraoperative an"],"journal":["BMC anesthesiology"],"pubmed_title":["A retrospective study of the safety and efficacy of peritoneal dialysis catheter placement under combined local infiltration anesthesia and monitored anesthesia care."],"pmcid":["PMC11468476"],"funding_grant_id":["2024NSCQ-MSX3483"],"pubmed_authors":["Shen J","Zheng X","Zhang J","Zhang H","Zhang L","Fang L","Zhao H"],"additional_accession":[]},"is_claimable":false,"name":"A retrospective study of the safety and efficacy of peritoneal dialysis catheter placement under combined local infiltration anesthesia and monitored anesthesia care.","description":"<h4>Objective</h4>Given the lack of global consensus on anesthesia selection for peritoneal dialysis catheter (PDC) placement via open surgery, this study investigates the safety and efficacy of combining local infiltration anesthesia (LIA) with monitored anesthesia care (MAC) in patients with end-stage renal disease (ESRD).<h4>Methods</h4>This retrospective analysis of ESRD patients who underwent open surgical placement of PDC in the Department of Nephrology, the First Affiliated Hospital of the Army Medical University from 1 August 2020 to 31 May 2022. Patients were categorized into two groups based on anesthesia method: LIA group and LIA + MA group. MA was defined as preoperative sedation (0.2-0.7 µg/kg/h) with dexmedetomidine injection (Huidrican trade name, DEX), and intraoperative an","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Oct","modification":"2025-04-26T07:53:38.513Z","creation":"2025-04-06T12:28:53.986Z"},"accession":"S-EPMC11468476","cross_references":{"pubmed":["39394070"],"doi":["10.1186/s12871-024-02751-y"]}}